LB Pharmaceuticals Announces $100.0 Million Private Placement
LB Pharmaceuticals Announces $100.0 Million Private Placement GlobeNewswire February 05, 2026 NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced that it has entered into a securities purchase agreement […]